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Abstract
Background: Tobacco addiction is a major cause of preventable death worldwide. Thus, efforts to eliminate its use
have the potential of producing significant health benefits. The purpose of this study was to conduct a meta-analysis
to estimate the prevalence of cigarette smoking among people in the age range of 15 to 64. The specific objective of
this meta-analysis was to provide valid data that policy makers can use to make evidence-based decisions.
Methods: To determine the prevalence of smoking among the adult population in northwest Iran, we used reports
published by the surveillance system used to assess the risk factors for non-communicable diseases in different
provinces in northwest Iran for the years 2004 and 2006-2009. Several variables were extracted, including the years
of study, gender, ages, and smoking prevalence. Based on the heterogeneity of the results, we used fixed or random
effects models to estimate the overall prevalence of cigarette smoking. The analyses were performed using Stata 11
software.
Results: A total of 28,436 subjects (14,248 males and 14,188 females) in five age groups, i.e., 15-24, 25-34, 35-44,
45-54, and 55-64, were interviewed. Meta-analysis in men showed that, across the age groups, the lowest prevalence
was 22.9%, the highest prevalence was 26.5%, and the average prevalence was 24.7%. Among women, the lowest
prevalence was 0.3%, the highest prevalence was 0.8%, and the average prevalence was 0.5%.
Conclusion: We found that approximately one-fourth of males in the age range of 15-64 in northwest Iran smoked
cigarettes daily.  Therefore, it is necessary to conduct effective interventions to reduce the prevalence of addiction to
tobacco in this area.
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1. Introduction
Cigarette smoking is one of the most important and pre-disposing risk factors associated with increasing the total
burden  of  disease,  especially  chronic  and  non-communicable diseases,  e.g.,  cancer  and  cardiovascular,
cerebrovascular, and respiratory diseases. Based on the reports of the U.S. Center for Disease Control, the lung
cancer mortality rates in men and women who smoke are 22 and 12 times greater than that of their non-smokingElectronic physician; Volume 6, Issue 1, January-March 2014 http://www.ephysician.ir
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counterparts, respectively; cigarette smoking is the most common cause of preventable deaths in the world (1-4). In
a 50-year study by Dol et al., smokers’ life expectancy was 10 years less than that of nonsmokers (5). Scientific
evidence has shown that smoking is harmful for those who smoke as well as those who are exposed to second-hand
cigarette smoke (6). Based on estimates provided by the World Health Organization (WHO), deaths related to
smoking will have decreased by 9% in developed countries between 2002 and 2030, but such deaths are expected to
double in developing countries over the same time period (7). During the 1990s, three million deaths annually were
attributable to cigarette smoking, and 67% of those deaths occurred in developed countries. In the next two decades,
this indicator will increase to 10 million deaths annually, 70% of which will be in developing countries (4, 7).
Recent research has shown that 14% of the Iranian people use tobacco in some form, with a male-to-female ratio of
6:1. In this report, the prevalence of smoking was estimated in different provinces in Iran, e.g., Ilam (7.6%), Yazd
(8.6%), and Golestan (9.1%), Sistan-Baloochistan (20.3%), and Booshehr (21.2%) (8). Other studies conducted in
the central and eastern parts of Iran, reported the prevalence to be between 17 and 26% for males and between 0.5
and 5.9% for females, but only few studies have estimated the prevalence of cigarette smoking in the northern and
western parts of Iran, and all of these studies were based on self-reporting questionnaires (9-17). The WHO also has
indicated that the prevalence of smoking in developing countries, such as Iran, is increasing (18-21). To reduce the
various smoking-related problems with effective interventions, investigations are required that use all available and
valid data, including the results of primary and secondary studies, i.e., the pooled results of studies and surveillance
conducted in Iran, particularly in northwest Iran. Since the national surveillance of the risk factors associated with
non-communicable diseases has included all provinces in Iran in recent years, the collection and pooling of the
results  via  meta-analysis  could  provide  important  data  that  policy  makers  could  use  to  make  evidence-based
decisions. Hence, this study aims to estimate the prevalence of cigarette smoking among people in the age range of
15-64 through the use of meta-analysis as a first step in a five-year national surveillance project in the northwest
provinces of Iran, including east and west Azarbayejan, Ardabil, and Qazvin.
2. Material and Methods
2.1. Selection of evidence
We  used  published  reports  that  resulted  from  the  first  step  of  the  non- communicable  disease  risk  factors
surveillance system in the northwest provinces of Iran for the years 2004 and 2006-2009. This national program was
launched in 2004 in accordance with WHO's guidelines to investigate the situation and trend of risk factors for non-
communicable  diseases,  such  as  smoking,  unhealthy  nutritional  habits,  low  physical  activity,  hypertension,
obesity/overweight, and diabetes mellitus among the population in the age range of 15-64. The first step of this
national project was conducted in 2004 and 2006-2009. These national studies were conducted using standardized
questionnaires. Sample selection in these studies relied on the Islamic Republic of Iran’s post office database using a
systematic approach and the one-stage cluster sampling method in all provinces. In each province, 50 postal codes
were selected randomly as executive clusters (seeds). The 50 clusters in2006-2009 included 20 subjects, but, in
2004, the number of clusters varied among the provinces. General information was collected through face-to-face
interviews in the participants’ homes.
2.2. Quality assessment
Since all reports selected for meta-analysis were conducted and published based on the standards of WHO with a
similar methodology in all provinces of Iran, no quality assessment was necessary. All questionnaires and equipment
for  data collection in  these  surveillance  projects  were  standardized  based  upon  WHO’s previously-validated
protocols (19).
2.3. Data extraction
We extracted data based on the year of study, total sample size, and the sample sizes in the gender and age groups.
Data  entry  was  done  using  an  Excel  spreadsheet.  The  validity  of  the  data  was  evaluated  by  two  independent
investigators who conducted some re-analysis of the raw data before conducting the statistical analyses.
2.4. Inclusion and exclusion criteria
Only the results acquired by the national non-communicable disease risk factors surveillance system (first step) over
a five-year period in northwest Iran were included in the study.
2.5. Statistical analysis
Stata V.11 software was used for the analyses. Smoking prevalence and its standard error were calculated for each
study based on the binary distribution formula. Tests of heterogeneity among the studies were calculated with aElectronic physician; Volume 6, Issue 1, January-March 2014 http://www.ephysician.ir
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Cochrane test (fixed model p > 0.05; random effects model p < 0.05), and the results were used to estimate the
pooled prevalence of cigarette smoking in the total population (random effects model) and within the gender and age
groups (fixed model in the age ranges of 15-24 and 35-44 due to non-significant Q statistics, and a random effects
model was used in the others that had significant Q statistics). In addition, to reduce the effect of random variation,
we used the Bayesian technique to estimate the pooled prevalence of smoking. Finally, using a meta-regression
technique, the effect of variables that were susceptible to heterogeneity among the studies was investigated. The
95% confidence interval of prevalence was estimated and demonstrated using forest plots (Figures 1 and 2).
3. Results
Based on national census data from 2006, the total population of north-west of Iran was 8,772,081 (East Azarbaijan:
3,527,267, West Azarbaijan: 2,873,459, Ardabil: 1,228,155, Qazvin: 1,143,200), which constituted approximately
12.5 percent of Iran’s total population. From this total population, a total of 28,436 people were interviewed (14,188
males and 14,248 females), and the interviewees included the following five age groups: 15-24, 25-34, 35-44, 45-54,
and 55-64. The sample size in 2004 was 12,436 people, and, over the following four years, 4,000 people were
recruited annually to participate in the study. The prevalence of cigarette smoking by males varied from 18.6% in
Qazvin Province (2007) to 28.5% in West Azarbaijan Province (2008). The pooled prevalence (95% CI) of smoking
by males in this meta-analysis was estimated to be 24.7%, with a range of 22.9 to 26.5%. By age and gender, the
prevalence of smoking for males in the 15-24 age range varied from 3% in Qazvin Province (2004) to 13% in West
Azarbaijan Province (2008); in  males in the 25-34 age range, the prevalence of smoking ranged  from 17% in
Ardabil Province (2004) to 37.6% in Ardabil (2009); in males in the 35-44 age range, the prevalence of smoking
ranged from 31% East Azarbaijan Province (YEAR) to 47.9% in Qazvin Province (2006); in males in the 45-54 age
range, the prevalence of  smoking ranged from 25.2% in East Azarbaijan Province (2007) to 52.5% percent in
Ardabil Province (2007); and, in males in the 55-64 age range, the prevalence of smoking ranged from 19.6% in
Qazvin Province (2006) to 44.4% in West Azarbaijan Province (2008). In females, the prevalence of cigarette
smoking varied from 0% in Qazvin Province (2009) to 1.28% in West Azarbaijan Province (2008). The pooled
prevalence of smoking in females was estimated to be 0.5%, with a range of 0.3% to 0.8%. Smoking prevalence
varied less than 1% in females in the age range of 15-24; 0% to 1.3% in females in the 25-34 age range; 0% to 7.7%
in females in 35-44 age range; 0% to 8.4% in females in the 45-54 age range; and 0% to 9% in females in the 55-64
age range. We added the year of the study in the meta-regression model if the heterogeneity of the studies was
significant, and we found no significant effect of the year of the study on the heterogeneity of the results (p > 0.05).
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Figure 1. Individual and pooled estimates of the prevalence of smoking among males: This chart shows that the
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Figure 2. Individual and pooled estimates of the prevalence of smoking among females: This chart shows that the
range of prevalence of smoking among females was 0.2% to 0.7% (based on Bayes analysis).
4. Discussion
Our meta-analysis showed that about 25% of male residents in northwest Iran were current cigarette smokers. If the
prevalence of other smoking products, such as hookahs and pipes, were considered along with cigarette smoking,
sizeable adverse effects would be expected among the people in this area. The prevalence of tobacco use seems to be
greater than it is in other regions of Iran. For example, in a study of Isfahan Province (Sarrafzadegan, YEAR), it was
found that, among 2626 people in the age range of 19 and up the prevalence of self-reported cigarette smoking in
males was 18.7% (9). Two other studies conducted in Tehran reported the prevalence of smoking among men at
20.6% and 22% (10, 11). In the city of Mashhad (in northeast Iran), 17.2% of males (172 of 999 subjects) were
current smokers, and the rates were higher among those with low incomes and low levels of education (12). In
another study, about 26% of males in the city of Shiraz (southern Iran) were found to be smokers (13). These
findings indicate that there is a high prevalence of cigarette smoking in males in all parts of Iran, including the
northwest area, which was the focus of the current study. Our study also showed that people in the 15-24 age range
smoked less than those in this age range in other countries, e.g., U.S.: 43.7%, Brazil: 14.7% and Malaysia: 29.7%, so
the differences could be attributable to cultural and social factors (11, 14).
Most of the male smokers were in 35-44 and 45-54 age groups. Table 1 shows that there was a significant difference
in smoking prevalence among men aged 15-24 compared to other age groups. This might have been partially due to
the fact that most of these younger age groups are educated in schools and are under full control and supervision of
their families and educational systems; they have had little opportunity for exposure in the community. The low
financial authority of young people within families in Iran could be another reason. It has also been shown that the
prevalence of smoking increased from the 15-24 to the 35-44 year old age groups, and, then, it decreased, which is
in agreement with the results of most other relevant studies (11). This reduction could be due to cigarette-related
diseases and mortality and better perception of its risks in the older age groups.
The estimated pooled prevalence of cigarette smoking among female residents of northwest of Iran was 0.5%; there
was an increasing trend by age, with women in the 55-64 age range smoking more than women in the other ageElectronic physician; Volume 6, Issue 1, January-March 2014 http://www.ephysician.ir
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groups. The rates in first three age groups were significantly different from those in older age groups. Some of the
studies in different parts of Iran reported similar findings. Fotouhi et al. (2009) and Ebadi et al. (2011) reported that
the prevalence of cigarette smoking by Iranian women was 2.9% and 2.1%, respectively (11, 15). The prevalence for
females in the 30 to 70 age range in Semnan (northern Iran) was 0.5%, while Mehrabi et al. (2007) found that 5.9%
of women in the 15 to 64 age range were smokers (16, 17). In Mashhad (northeast Iran), 2.5% of the women smoke
cigarettes,  while, in Shiraz (southern Iran), 3.6% of  women  smoke (12, 13). This relatively low prevalence of
cigarette smoking in women is similar to other Middle Eastern and South Asian countries. For instance, a study in
Pakistan showed that 5% of females in the 25-44 age range smoke and that 7.8% in the 45-64 age range smoke (22).
In Egypt, 1.5% of females in the 15 to 80 age range smoke, and, in Kuwait, 1.9% of adult females currently smoke
(23-24). Interestingly, the prevalence of cigarette smoking in female adults in Italy was 22.5%, and, in the U.S., it
was 17.4% (25, 26). The current study has shown that smoking among women is less prevalent in Iran than in most
other countries.
We also found that the prevalence of cigarette smoking in males was considerably more than that of women in all
age groups. This pattern was similar in all other studies in Iran and in other countries, including China, Korea,
European countries, and the U.S. (27-30). Patterns of cigarette smoking depend on different factors, such as age,
gender, level of education, and socioeconomic class and development (10). Ebadi et al. (2011) showed that, with
each year of increase in age, a 2% increase in the prevalence of smoking occurs and that each level of education
decreases that prevalence by approximately 5%. Five times more males than females smoke cigarettes, employed
people smoke slightly more than retired people, and people who are jobless smoke twice as much as people who are
employed. He also reported that divorced people smoke more than any other category (15).
One of the main causes of variations in the results of different studies is likely due to the various definitions of
smoking that are used, e.g., defining “smokers” according to the number of cigarettes smoked in a given time period,
the duration of smoking, and time a person spends smoking each day. Another source of heterogeneity was the
determination of prevalence based on the self-reporting of study subjects, which can lead to recall bias and interview
bias. The magnitude of this bias is different in various populations, based on their socio-cultural situations and their
levels  of  acceptance  of  smoking  and  the  stigma  associated  with  it.  Thus,  self-reporting  was  one  of  the  main
limitations in this study, because the socio-cultural situation and lack of social acceptance of smoking could have
increased the probability of underreporting the prevalence of smoking in both genders (especially females) to a
greater extent than in studies conducted in other countries. The method of data collection in the original surveillance
project was based on the ‘self-report’ method and also face-to-face interviews, which are prone to respondents’
biases. Unfortunately, no objective markers were used for verification of the real exposure to cigarette smoke. For
example, in a recent study, the prevalence of smoking based on the ‘self-report’ method was 18.7% and 1.3% in men
and women, respectively. But laboratory tests have shown that these rates were actually 21.2% and 6.7% percent,
respectively (9). Therefore, we can expect that our reported prevalence is an underestimation for both males and
females, but especially for females.
5. Conclusion
In this study, the prevalence of cigarette smoking was estimated using valid data and meta-analysis. Our estimation
of  the  prevalence  of  cigarette  smoking  indicated  that  smoking  continues  to  be  a  main  health  problem  in  the
northwest  provinces  of  Iran.  Therefore,  it  is  necessary  for  policy  makers  to  conduct  and  support  effective
intervention with the goal of reducing the prevalence of smoking in these provinces.
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